Hunting Hill Global Capital’s Checkpoint Therapeutics CKPT Stock Holding History

Hunting Hill Global Capital’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-57,200	Closed	-$231K	–	130
2025 Q1	$231K	Buy	+57,200	New	+$191K	0.14%	76

Hunting Hill Global Capital's CKPT Position: Q2 2025 in Review

Hunting Hill Global Capital sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 57,200 shares — an estimated $231K sold.

Hunting Hill Global Capital first reported a position in CKPT in Q1 2025 and held it in 1 quarter. The position peaked at $231K in Q1 2025. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

Hunting Hill Global Capital reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
Hunting Hill Global Capital sold 57,200 Checkpoint Therapeutics shares in Q2 2025, an estimated $231K.
Hunting Hill Global Capital first reported a position in Checkpoint Therapeutics in Q1 2025 and held it in 1 quarter.
Hunting Hill Global Capital's Checkpoint Therapeutics position peaked at $231K in Q1 2025.
0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on Hunting Hill Global Capital's 13F filing for Q2 2025, filed 14 Aug 2025.